Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network
Haemophilia · 2024
DOI: 10.1111/hae.15033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, 2024. Verfasst von Sandrine Meunier und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hospices Civils de Lyon- Centre de Référence Hémophilie - Unité d'Hémostase Clinique CHU de Lyon, Bron, France. Hauptthemen laut MEDLINE: Hemorrhage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
In the context of severe unexplained haemorrhage (SH), it is usual to seek haematological evaluation and investigate for an inherited rare bleeding disorder (IRBD). In such circumstances, appropriate screen can discriminate between IRBD and suspected child abuse. Yet, little information is available about the frequency of SH in the population of patients with IRBD.
Aim
To collect epidemiologic data about SH and IRBD.
Method
The database of the FranceCoag network has collected information about IRBD since January 2004. Based on data gathered up to 16 March 2022, a retrospective search was conducted for of SH events having occurred before or at the time of IRBD diagnosis. Demographics and diagnosis circumstances were retrieved, as well as information about SH, defined as any life‐threatening bleeding or intracranial haemorrhage.
Results
Among the 13,433 patients of the database, 109 (0.8%) fulfilled inclusion criteria including a known date of IRBD diagnosis, haemophilia A or B (HA/HB) being the most frequent (82.5%). IRBD was discovered as a consequence of an SH event in 82.6% of the cases while CNS was involved in 55%. Severe and moderate HA/HB and other severe IRBD presented significantly more intracranial haemorrhage ( p < .02) and a lower age at diagnosis ( p = .03).
Conclusions
These data support that any unusual SH should raise a suspicion of IRBD. Particularly before 1‐year of age, it is suggested to first confirm moderate or severe haemophilia and severe IRBD by standard coagulation tests (APTT, PT and fibrinogen), combined with a clotting FXIII assay as first‐line investigation. Subsequent assays of coagulation factors should be performed in the case of abnormal values, in second‐line investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospices Civils de Lyon- Centre de Référence Hémophilie - Unité d'Hémostase Clinique CHU de Lyon, Bron, France.
- Service d'Hématologie Clinique Centre de Traitement de l'Hémophilie, Hôpital Necker Enfants Malades, AP-HP, Paris, France.
- Unité d'Hémostase Clinique et Biologique - Pôle d'Hématologie Transfusion - Institut Cœur Poumon, Lille, France.
- Centre de Ressources et de Compétences Maladies Hémorragiques Constitutionnelles, Bordeaux, France.
- FranceCoag Network, APHM, Marseille, France.
- Centre de Traitement des Hémophiles, Hôpital Universitaire La Timone, Marseille, France.
ORCID-Profile: Sandrine Meunier, Annie Harroche, Antoine Rauch
Zitieren
APA
Meunier, S., Harroche, A., Rauch, A., Bally, C., Huguenin, Y., Voltzenlogel, R., Tabélé, C., Chambost, H., Balençon, M., & FranceCoag (2024). Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network. Haemophilia. https://doi.org/10.1111/hae.15033
Vancouver
Meunier S, Harroche A, Rauch A, Bally C, Huguenin Y, Voltzenlogel R, et al. Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network. Haemophilia. 2024. doi:10.1111/hae.15033
BibTeX
@article{Meunier2024,
author = {Meunier, Sandrine and Harroche, Annie and Rauch, Antoine and Bally, Cécile and Huguenin, Yoann and Voltzenlogel, Romain and Tabélé, Clémence and Chambost, Hervé and Balençon, Martine and FranceCoag, FranceCoag},
title = {Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network},
journal = {Haemophilia},
year = {2024},
doi = {10.1111/hae.15033}
}
EUVIMED